Skip to main content

Table 3 Cox proportional hazards model multivariable analysis for survival

From: Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

Factor

Univariable HR (95% C.I)

p

Multivariable HR (95% C.I)

p

Blood NLR (< 4)

0.63 (0.47–0.84)

0.01

0.66 (0.45–0.96)

0.03

Pleural fluid lymphocyte predominance

0.52 (0.33–0.82)

0.01

0.53 (0.32–0.89)

0.02

Lymphocytic stroma predominance

0.74 (0.59–0.93)

0.01

0.55 (0.35–0.87)

0.01

Age (per year)

1.02 (1.01–1.04)

0.01

0.98 (0.95–1.01)

0.15

Male gender

0.85 (0.56–1.29)

0.45

0.66 (0.40–1.10)

0.11

WHO PS (3–4)

1.37 (1.12–1.67)

0.01

2.60 (1.72–3.92)

0.01

Epithelioid sub type

0.61 (0.44–0.846)

0.01

0.60 (0.39–0.93)

0.02

Radiological Stage (1 & 2 vs 3 & 4)

0.95 (0.53–1.69)

0.08

0.74 (0.32–1.69)

0.47

Received chemotherapy

0.52(0.40–0.70)

0.01

0.58 (0.40–0.84)

0.04

  1. NLR neutrophil/lymphocyte ratio, p < 0.05 defined as significant